| Financial Year |
March 31 2023 |
| Monetary Funds |
502,047,193.38 |
| Held-for-trading Financial Assets |
27,827,247.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
68,400,324.16 |
| Advances to Suppliers |
41,654,348.99 |
| Other Receivables |
225,255,866.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
96,714,152.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,650,926.39 |
| Total Current Assets |
977,550,058.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,250,978.60 |
| Investment Properties |
46,495,921.73 |
| Fixed Assetes |
163,805,616.02 |
| Under-construction Projects |
7,018,551.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
57,932,208.59 |
| R&D expenses |
-- |
| Goodwill |
424,598,843.38 |
| Long-Term Deferred and Prepaid Expenses |
103,215,262.98 |
| Deferred Income Tax Assets |
1,075,165.91 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
974,999,002.60 |
| Total Assets |
1,952,549,060.80 |
| Short-Term Loans |
230,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
59,525,067.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,227,134.27 |
| Taxes Payable |
1,187,626.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
46,044,049.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,412,103.76 |
| Other Current Liabilities |
7,829,409.54 |
| Sub-Total of Current Liabilities |
384,534,097.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,355,591.17 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
146,713,327.04 |
| Total Liabilities |
531,247,424.64 |
| Paid-In Capital(Or Share Stock) |
374,306,455.00 |
| Capital Surplus |
1,883,465,365.55 |
| Surplus Reserve |
8,157,086.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-926,040,671.09 |
| Minority Stockholder's Interest |
81,304,020.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,339,997,615.51 |
| Owner's Equity（Stockholder's Equity） |
1,421,301,636.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,952,549,060.80 |
